GT Biopharma, Inc.
GTBP· Nasdaq
GTBPGT Biopharma, Inc.
Filed May 21, 2012 · 10-Q · 51 days after period end · 0001513160-12-000042
| Metric | Q1 2012 | Q1 2011 |
|---|---|---|
| Revenue | $1.00K | $20.00K |
| Net Income | -$615.00K | -$1.92M |
| EPS Diluted | $0.00 | -$0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
GT Biopharma, Inc. · CIK 109657 · Engraved from SEC EDGAR
ended Mar 31, 2012 · filed May 21, 2012 · 51 d after period end
